{
    "Orphapacket": {
        "ORPHApacketId": "466",
        "creationDate": "2023-12-06 11:51:54",
        "version": "1.3.29 / 4.1.7 [2023-08-02] (orientdb version)",
        "copyright": "Orphanet (c) 2023",
        "ORPHAcode": "466",
        "Label": "Fatal familial insomnia",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_466",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "600072",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A rare inherited human prion disease characterized by adult onset of progressive disturbance and loss of circadian rhythms dysautonomia with increased sympathetic activity and cognitive impairment with fluctuating vigilance impaired long-term memory disorientation and oneiric states. Motor disturbances include myoclonus cerebellar ataxia and pyramidal signs. The disease rapidly leads to a somnolent or comatose state and is typically fatal after 9 or 30 months on average (bimodal course). Neuropathologic examination shows marked neuronal loss and gliosis predominantly in thalamic nuclei and inferior olives while deposition of abnormal prion protein may be relatively sparse."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "PRNP",
                    "Name": "prion protein",
                    "ExternalReferences": [],
                    "DisorderGeneAssociationType": "Disease-causing germline mutation(s) in"
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "280400",
                        "Label": "Inherited human prion disease"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Cases/families",
                    "PrevalenceQualification": "Case",
                    "PrevalenceClass": "no data",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            },
            {
                "Prevalence": {
                    "Source": "ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            }
        ],
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "Adult"
                }
            ]
        },
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Autosomal dominant"
                }
            ]
        }
    }
}